BELARDINILLI FRANCESCA^1,#, MICHELA DE MEO^1,#, FRANCESCO DEL GIUDICE², CARLO MARIA SCORNAJENGHI², PAOLA GAZZANIGA¹, ETTORE DE BERARDINIS², LUCA MARINO³, FABIO MASSIMO MAGLIOCCA⁴, BENJAMIN INBEH CHUNG⁵, JAN ŁASZKIEWICZ⁶, VALENTINA MAGRI⁴, GIUSEPPE GIANNINI^1,7, CHIARA NICOLAZZO^1,*

Oncology Research, Vol.33, No.3, pp. 723-731, 2025, DOI:10.32604/or.2024.056282 - 28 February 2025

Abstract Objectives: Intravesical Bacillus Calmette-Guérin (BCG) therapy is a gold standard for patients with high-risk non-muscle invasive bladder cancer (NMIBC). Although a long-lasting therapeutic response is observed in most patients, BCG failure occurs in 30%–50% of patients and a progression to muscle-invasive disease is found in 10%–15%. Therefore, predicting high-risk patients who might not benefit from BCG treatment is critical. The purpose of this study was to identify, whether the presence of specific oncogenic mutations might be indicative of BCG treatment response. Methods: Nineteen high-grade NMIBC patients who received intravesical BCG were retrospectively enrolled and divided… More > Graphic Abstract

LI SUN^1,#, SHICHAO ZHUO^2,#, XIAOXIN LI², HUSHENG KONG³, WEIWEI DU³, CHONG ZHOU⁴, JUNXING HUANG^1,*

Oncology Research, Vol.33, No.3, pp. 641-651, 2025, DOI:10.32604/or.2024.050057 - 28 February 2025

Abstract Background: Cisplatin (DDP) has been used in the treatment of various human cancers. However, DDP alone lacks efficacy in treating triple-negative breast cancer (TNBC), and its clinical application is often hampered by side effects. Astragalus polysaccharide (APS) is one of the active components extracted from Astragalus membranaceus and has gained attention for its various biological properties. This research is aimed to evaluate the effectiveness of a combination of APS and DDP on TNBC and explore the potential mechanisms. Methods: The efficacy and mechanisms of single or combined treatment were evaluated using Cell Counting Kit-8 (CCK8) assay, Annexin… More >

Ikram Belmehdi^1,*, Boumedienne Beladjine¹, Mohamed Djermouni¹, Amina Sabeur¹, Mohammed El Ganaoui²

FDMP-Fluid Dynamics & Materials Processing, Vol.21, No.1, pp. 71-85, 2025, DOI:10.32604/fdmp.2024.058510 - 24 January 2025

Abstract The objective of this study is to propose an optimal plant design for blue hydrogen production aboard a liquefied natural gas (LNG) carrier. This investigation focuses on integrating two distinct processes—steam methane reforming (SMR) and ship-based carbon capture (SBCC). The first refers to the common practice used to obtain hydrogen from methane (often derived from natural gas), where steam reacts with methane to produce hydrogen and carbon dioxide (CO₂). The second refers to capturing the CO₂ generated during the SMR process on board ships. By capturing and storing the carbon emissions, the process significantly reduces its… More >

XIANG LI^1,#, WENKE JIN^2,#, LIFENG WU², HUAN WANG¹, XIN XIE¹, WEI HUANG^1,*, BO LIU^2,*

Oncology Research, Vol.33, No.1, pp. 67-81, 2025, DOI:10.32604/or.2024.055921 - 20 December 2024

Abstract Background: Triple-negative breast cancer (TNBC), characterized by its lack of traditional hormone receptors and HER2, presents a significant challenge in oncology due to its poor response to conventional therapies. Autophagy is an important process for maintaining cellular homeostasis, and there are currently autophagy biomarkers that play an effective role in the clinical treatment of tumors. In contrast to targeting protein activity, intervention with protein-protein interaction (PPI) can avoid unrelated crosstalk and regulate the autophagy process with minimal interference pathways. Methods: Here, we employed Naive Bayes, Decision Tree, and k-Nearest Neighbors to elucidate the complex PPI… More >

WEI ZHANG^1,3,#, WEICHENG WANG^1,#, RUI WANG¹, XIAO HAN¹, LIJUN ZHU¹, WENJIE GUO^2,*, YANHONG GU^1,*

Oncology Research, Vol.33, No.1, pp. 225-234, 2025, DOI:10.32604/or.2024.050047 - 20 December 2024

Abstract Background: As a novel blocker of vascular endothelial growth factor receptor (VEGFR), fruquintinib has been approved for treating colorectal cancer (CRC). However, its dosage and therapeutic efficacy are limited by its widespread adverse reactions. Venetoclax, recognized as the initial inhibitor of B-cell lymphoma protein 2 (BCL2), has shown potential in boosting the effectiveness of immunotherapy against CRC. This study investigated the efficacy and mechanisms of fruquintinib combined with venetoclax in treating CRC. Methods and Materials: We developed a colon cancer mouse model with the CT26 colon cell line to demonstrate fruquintinib and venetoclax’s efficacy against tumors.… More > Graphic Abstract

WEN YANG, BIN TANG, DAN XU, WENXIU YANG^*

Oncology Research, Vol.33, No.1, pp. 199-212, 2025, DOI:10.32604/or.2024.050036 - 20 December 2024

Abstract Background: The prognostic significance of the chemokine receptor CCR7 in diffuse large B-cell lymphoma (DLBCL) has been reported previously. However, the detailed mechanisms of CCR7 in DLBCL, particularly regarding its interaction with lenalidomide treatment, are not fully understood. Methods: Our study utilized bioinformatics approaches to identify hub genes in SU-DHL-2 cell lines treated with lenalidomide compared to control groups. Immunohistochemical data and clinical information from 122 patients with DLBCL were analyzed to assess the correlation of CCR7 and p-ERK1/2 expression with the prognosis of DLBCL. Furthermore, in vitro and in vivo experiments were conducted to clarify the… More > Graphic Abstract

XUETING HUANG¹, CHAOJIE XU², CHEN LI^3,*, ZHIXIAN PAN^1,*

BIOCELL, Vol.48, No.12, pp. 1805-1813, 2024, DOI:10.32604/biocell.2024.056431 - 30 December 2024

Abstract Background: Hyperuricemia is a metabolic disorder which is characterized by increased serum uric acid levels, which can contribute to serious health issues such as gout, cardiovascular disease, and kidney damage. Epigenetic modifications, for example, DNA methylation, exert a crucial function in gene regulation and have been implicated in various metabolic disorders. The ATP-Binding Cassette Subfamily G Member 2 (ABCG2) gene is involved in uric acid excretion, and its expression can be influenced by methylation of its promoter region. Methods: This study involved the design of three guide RNA (gRNA) sequences targeting specific CpG sites within… More >

Vladimir Konovalov^*

FDMP-Fluid Dynamics & Materials Processing, Vol.20, No.11, pp. 2541-2563, 2024, DOI:10.32604/fdmp.2024.051219 - 28 October 2024

Abstract The regime of horizontal subcooled film boiling is characterized by the formation of a thin layer of vapor covering the surface of a flat horizontal heater. Based on the equations of motion of a viscous incompressible fluid and the equation of heat transfer, the stability of such a vapor film is investigated. The influence of the modulation of the gravity field caused by vertical vibrations of the heater of finite frequency, as well as a constant electric field applied normal to the surface of the heater, is taken into account. It is shown that in… More >

JINXIA CHEN^1,2,3,#, SULI DAI^1,2,#, GENG ZHANG^4,5, SISI WEI^1,2, XUETAO ZHAO³, YANG ZHENG^1,2, YAOJIE WANG^1,2, XIAOHAN WANG^1,2, YUNJIANG LIU^4,5,*, LIANMEI ZHAO^1,2,*

Oncology Research, Vol.32, No.11, pp. 1791-1802, 2024, DOI:10.32604/or.2024.049348 - 16 October 2024

Abstract Background: Triple-negative breast cancer (TNBC) is a heterogeneous, recurring cancer characterized by a high rate of metastasis, poor prognosis, and lack of efficient therapies. KBU2046, a small molecule inhibitor, can inhibit cell motility in malignant tumors, including breast cancer. However, the specific targets and the corresponding mechanism of its function remain unclear. Methods: In this study, we employed (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H tetrazolium) (MTS) assay and transwell assay to investigate the impact of KBU2046 on the proliferation and migration of TNBC cells in vitro. RNA-Seq was used to explore the targets of KBU2046 that inhibit the motility of TNBC.… More > Graphic Abstract

Jie Zhang¹, Xu Zhou¹, Sanqiang Yang¹, Moubin Liu^1,*

The International Conference on Computational & Experimental Engineering and Sciences, Vol.29, No.2, pp. 1-2, 2024, DOI:10.32604/icces.2024.012192

Abstract The lattice architecture, characterized by its methodical arrangement of repetitive units, exhibits compactness, uniformity, and lightweight properties. In additive manufacturing, such structures are widely utilized in support structures and internal fillings, playing a significant role in improving manufacturing efficiency and optimizing structural performance [1,2]. However, due to the complex microstructure of lattice materials, it is challenging to describe them using refined finite element models. The development of an equivalent performance model for these materials, employing a periodic single cell to represent the internal architecture for the comprehensive lattice system, can significantly improve computational efficiency and… More >